Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

312 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.
Flament-Saillour M, Robert J, Jarlier V, Grosset J. Flament-Saillour M, et al. Among authors: jarlier v. Am J Respir Crit Care Med. 1999 Aug;160(2):587-93. doi: 10.1164/ajrccm.160.2.9901012. Am J Respir Crit Care Med. 1999. PMID: 10430733
[Analysis of restriction fragment length polymorphism (RFLP) of Mycobacterium tuberculosis strains isolated from patients with several episodes of tuberculosis].
Lemaitre N, Sougakoff W, Truffot C, Grosset J, Jarlier V. Lemaitre N, et al. Among authors: jarlier v. Pathol Biol (Paris). 1996 May;44(5):452-5. Pathol Biol (Paris). 1996. PMID: 8758493 French.
[What are the new diagnostic tools in tuberculosis? What is their role in disease management and what are their indications? Gene amplification tests].
Jarlier V, Cambau E, Sougakoff W. Jarlier V, et al. Rev Mal Respir. 2004 Jun;21(3 Pt 2):S36-43. doi: 10.1016/s0761-8425(04)71383-2. Rev Mal Respir. 2004. PMID: 15344268 Review. French. No abstract available.
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries.
Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, Rüsch-Gerdes S, Gutiérrez J, Jarlier V. Casal M, et al. Among authors: jarlier v. Microb Drug Resist. 2005 Spring;11(1):62-7. doi: 10.1089/mdr.2005.11.62. Microb Drug Resist. 2005. PMID: 15770097
[Multi-resistant tuberculosis in France].
Robert J, Jarlier V. Robert J, et al. Among authors: jarlier v. Rev Mal Respir. 2002 Feb;19(1):21-3. Rev Mal Respir. 2002. PMID: 17546806 French. No abstract available.
Mycobacterium avium complex common-source or cross-infection in AIDS patients attending the same day-care facility.
Carbonne A, Lemaitre N, Bochet M, Truffot-Pernot C, Katlama C, Grosset J, Bricaire F, Jarlier V. Carbonne A, et al. Among authors: jarlier v. Infect Control Hosp Epidemiol. 1998 Oct;19(10):784-6. doi: 10.1086/647725. Infect Control Hosp Epidemiol. 1998. PMID: 9801289
A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.
Robert J, Boulahbal F, Trystram D, Truffot-Pernot C, de Benoist AC, Vincent V, Jarlier V, Grosset J. Robert J, et al. Among authors: jarlier v. Int J Tuberc Lung Dis. 1999 Aug;3(8):711-4. Int J Tuberc Lung Dis. 1999. PMID: 10460104
A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union.
Bernard C, Brossier F, Sougakoff W, Veziris N, Frechet-Jachym M, Metivier N, Renvoisé A, Robert J, Jarlier V; MDR-TB Management group of the NRC. Bernard C, et al. Among authors: jarlier v. Euro Surveill. 2013 Aug 15;18(33):20555. doi: 10.2807/1560-7917.es2013.18.33.20555. Euro Surveill. 2013. PMID: 23968874
French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission.
Lepelletier D, Berthelot P, Lucet JC, Fournier S, Jarlier V, Grandbastien B; National Working Group. Lepelletier D, et al. Among authors: jarlier v. J Hosp Infect. 2015 Jul;90(3):186-95. doi: 10.1016/j.jhin.2015.04.002. Epub 2015 Apr 24. J Hosp Infect. 2015. PMID: 25986165 Review.
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis.
Ibrahim M, Andries K, Lounis N, Chauffour A, Truffot-Pernot C, Jarlier V, Veziris N. Ibrahim M, et al. Among authors: jarlier v. Antimicrob Agents Chemother. 2007 Mar;51(3):1011-5. doi: 10.1128/AAC.00898-06. Epub 2006 Dec 18. Antimicrob Agents Chemother. 2007. PMID: 17178794 Free PMC article.
312 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback